Back to Search
Start Over
Supplementary Figure Legends from A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure Legends S1-S5
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....8264f8a52ff80ce649d98a844679d150
- Full Text :
- https://doi.org/10.1158/1078-0432.22463274.v1